News & Updates
Filter by Specialty:
Disease-modifying agents for multiple sclerosis do not elevate cancer risk
Several disease-modifying therapies (DMTs) for multiple sclerosis (MS) do not pose an increased risk of cancer, a study has shown.
Disease-modifying agents for multiple sclerosis do not elevate cancer risk
09 Jan 2022
Opioid use lowers LOS, deaths in nonmetastatic CRC patients
Use of opioids in the long term leads to shorter length of stay (LOS) and reduced inpatient mortality among patients hospitalized with nonmetastatic colorectal cancer (CRC), results of a study have shown. However, patients with cancer-related complications endure longer LOS and higher mortality than those admitted without such morbidities.
Opioid use lowers LOS, deaths in nonmetastatic CRC patients
09 Jan 2022
Diabetes mellitus may worsen COVID-19
Diabetes mellitus (DM) raises the risk of mortality and respiratory failure, as well as the need for intensive care, among patients with the coronavirus disease 2019 (COVID-19), reports a recent Philippine study.
Diabetes mellitus may worsen COVID-19
09 Jan 2022
Shorter time from rectal cancer diagnosis to NCRT tied to pathologic complete response
The time elapsed between diagnosis of rectal cancer and initiation of neoadjuvant chemoradiation (NCRT) shows a significant association with pathologic complete response (pCR), and shortening this time may improve the likelihood of achieving pCR, suggests a recent study.
Shorter time from rectal cancer diagnosis to NCRT tied to pathologic complete response
08 Jan 2022
Dry eye disease symptoms, incidence worsen during COVID-19 lockdown
There was an increase in the incidence of dry-eye disease (DED) during the lockdown for the coronavirus disease 2019 (COVID-19), a recent study has found. Such a spike may be related to the increase in use of visual display terminals (VDTs).